Last 12 months
Inside the activity.
0 purchase rows · 20 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 7 |
| Mar 2026 | 0 | 3 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 2 |
| Aug 2026 | 0 | 5 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 24, 2025 Filed Jul 28, 2025 19:59 UTC |
ANDERSON KERRII BDirector
|
SaleCommon Stock | 3,500 | $280.00 | $980,000.00 |
DisclosureSEC source: 0001127602-25-019625 · form4.xml · nonDerivative · entry 1 ANDERSON KERRII B · CIK 0001227159 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,666 F1 · kind: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Read SEC document |
| July 01, 2025 Filed Jul 2, 2025 14:37 UTC |
ANDERSON KERRII BDirector
|
SaleCommon Stock | 500 | $265.00 | $132,500.00 |
DisclosureSEC source: 0001127602-25-018440 · form4.xml · nonDerivative · entry 1 ANDERSON KERRII B · CIK 0001227159 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,166 F1 · kind: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Read SEC document |
| June 11, 2025 Filed Jun 12, 2025 14:07 UTC |
ANDERSON KERRII BDirector
|
SaleCommon Stock | 500 | $260.00 | $130,000.00 |
DisclosureSEC source: 0001127602-25-017341 · form4.xml · nonDerivative · entry 1 ANDERSON KERRII B · CIK 0001227159 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,666 F1 · kind: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Read SEC document |
| June 03, 2025 Filed Jun 5, 2025 12:19 UTC |
Caveney Brian JEVP, Pres of ED, CMO & CSO
|
SaleCommon Stock | 2,000 | $247.00 | $494,000.00 |
DisclosureSEC source: 0001127602-25-016812 · form4.xml · nonDerivative · entry 1 Caveney Brian J · CIK 0001717915 · EVP, Pres of ED, CMO & CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,066.6573 Read SEC document |
| May 12, 2025 Filed May 13, 2025 14:01 UTC |
Schechter Adam HDirector · President & CEO
|
SaleCommon Stock | 6,105 | $248.73 | $1,518,496.65 |
DisclosureSEC source: 0001127602-25-014013 · form4.xml · nonDerivative · entry 1 Schechter Adam H · CIK 0001376841 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 98,962 F1 · kind: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 01, 2025 Filed May 5, 2025 16:45 UTC |
van der Vaart Sandra DEVP, Chief Legal Officer
|
SaleCommon Stock | 1,900 | $238.36 | $452,884.00 |
DisclosureSEC source: 0001127602-25-013311 · form4.xml · nonDerivative · entry 1 van der Vaart Sandra D · CIK 0001537208 · EVP, Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,243.5397 Read SEC document |
| May 01, 2025 Filed May 5, 2025 16:45 UTC |
Wilkinson Peter JSVP, Chief Accounting Officer
|
SaleCommon Stock | 829 | $242.27 | $200,837.69 |
DisclosureSEC source: 0001127602-25-013310 · form4.xml · nonDerivative · entry 1 Wilkinson Peter J · CIK 0001398138 · SVP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,054.2194 Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 12:47 UTC |
Bailey Megan D.EVP, Pres, Central Labs & Intl
|
Exercise / conversionRestricted Stock Unit · Derivative | 204 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-011280 · form4.xml · derivative · entry 6 Bailey Megan D. · CIK 0001975682 · EVP, Pres, Central Labs & Intl 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,969 Underlying: Common Stock · 204 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. F5 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in two equal installments beginning on April 1, 2024 and are now fully vested. F5 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in two equal installments beginning on April 1, 2024 and are now fully vested. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 12:47 UTC |
Bailey Megan D.EVP, Pres, Central Labs & Intl
|
Exercise / conversionRestricted Stock Unit · Derivative | 4,083 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-011280 · form4.xml · derivative · entry 5 Bailey Megan D. · CIK 0001975682 · EVP, Pres, Central Labs & Intl 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,173 Underlying: Common Stock · 4,083 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units vested on April 1, 2025. F3 · derivative.expiration_date: The Restricted Stock Units vested on April 1, 2025. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 12:47 UTC |
Bailey Megan D.EVP, Pres, Central Labs & Intl
|
Tax withholdingCommon Stock | 68 | $232.65 | $15,820.20 |
DisclosureSEC source: 0001127602-25-011280 · form4.xml · nonDerivative · entry 4 Bailey Megan D. · CIK 0001975682 · EVP, Pres, Central Labs & Intl 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,403 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 12:47 UTC |
Bailey Megan D.EVP, Pres, Central Labs & Intl
|
Exercise / conversionCommon Stock | 204 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-011280 · form4.xml · nonDerivative · entry 3 Bailey Megan D. · CIK 0001975682 · EVP, Pres, Central Labs & Intl 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,471 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 12:47 UTC |
Bailey Megan D.EVP, Pres, Central Labs & Intl
|
Tax withholdingCommon Stock | 1,546 | $232.65 | $359,676.90 |
DisclosureSEC source: 0001127602-25-011280 · form4.xml · nonDerivative · entry 2 Bailey Megan D. · CIK 0001975682 · EVP, Pres, Central Labs & Intl 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,267 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 12:47 UTC |
Bailey Megan D.EVP, Pres, Central Labs & Intl
|
Exercise / conversionCommon Stock | 4,083 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-011280 · form4.xml · nonDerivative · entry 1 Bailey Megan D. · CIK 0001975682 · EVP, Pres, Central Labs & Intl 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,813 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. Read SEC document |
| March 28, 2025 Filed Mar 31, 2025 14:47 UTC |
Summy Amy B.EVP, Chief Marketing Officer
|
SaleCommon Stock | 758 | $231.67 | $175,605.86 |
DisclosureSEC source: 0001127602-25-010627 · form4.xml · nonDerivative · entry 3 Summy Amy B. · CIK 0001805303 · EVP, Chief Marketing Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,301.5 F3 · kind: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Read SEC document |
| March 28, 2025 Filed Mar 31, 2025 14:39 UTC |
Schroeder Mark SEVP, Pres Diagnostics & COO
|
SaleCommon Stock | 2,635 | $231.67 | $610,450.45 |
DisclosureSEC source: 0001127602-25-010624 · form4.xml · nonDerivative · entry 3 Schroeder Mark S · CIK 0001793112 · EVP, Pres Diagnostics & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,960.1426 F3 · kind: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Read SEC document |
| March 27, 2025 Filed Mar 31, 2025 14:47 UTC |
Summy Amy B.EVP, Chief Marketing Officer
|
Tax withholdingCommon Stock | 562 | $231.67 | $130,198.54 |
DisclosureSEC source: 0001127602-25-010627 · form4.xml · nonDerivative · entry 2 Summy Amy B. · CIK 0001805303 · EVP, Chief Marketing Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,059.5 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| March 27, 2025 Filed Mar 31, 2025 14:47 UTC |
Summy Amy B.EVP, Chief Marketing Officer
|
GrantCommon Stock | 2,077 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-010627 · form4.xml · nonDerivative · entry 1 Summy Amy B. · CIK 0001805303 · EVP, Chief Marketing Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,621.5 F1 · kind: Shares acquired on March 27, 2025, pursuant to a performance award granted on February 11, 2022, relating to performance during the three-year period ended December 31, 2024. Read SEC document |
| March 27, 2025 Filed Mar 31, 2025 14:39 UTC |
Schroeder Mark SEVP, Pres Diagnostics & COO
|
Tax withholdingCommon Stock | 2,205 | $231.67 | $510,832.35 |
DisclosureSEC source: 0001127602-25-010624 · form4.xml · nonDerivative · entry 2 Schroeder Mark S · CIK 0001793112 · EVP, Pres Diagnostics & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,595.1426 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| March 27, 2025 Filed Mar 31, 2025 14:39 UTC |
Schroeder Mark SEVP, Pres Diagnostics & COO
|
GrantCommon Stock | 4,840 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-010624 · form4.xml · nonDerivative · entry 1 Schroeder Mark S · CIK 0001793112 · EVP, Pres Diagnostics & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,800.1426 F1 · kind: Shares acquired on March 27, 2025, pursuant to a performance award granted on February 11, 2022, relating to performance during the three-year period ended December 31, 2024. Read SEC document |
| March 27, 2025 Filed Mar 31, 2025 14:27 UTC |
Schechter Adam HDirector · President & CEO
|
Tax withholdingCommon Stock | 13,584 | $231.67 | $3,147,005.28 |
DisclosureSEC source: 0001127602-25-010619 · form4.xml · nonDerivative · entry 2 Schechter Adam H · CIK 0001376841 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,067 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| March 27, 2025 Filed Mar 31, 2025 14:27 UTC |
Schechter Adam HDirector · President & CEO
|
GrantCommon Stock | 30,469 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-010619 · form4.xml · nonDerivative · entry 1 Schechter Adam H · CIK 0001376841 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 118,651 F1 · kind: Shares acquired on March 27, 2025, pursuant to a performance award granted on February 11, 2022, relating to performance during the three-year period ended December 31, 2024. Read SEC document |
| March 27, 2025 Filed Mar 31, 2025 14:35 UTC |
van der Vaart Sandra DEVP, Chief Legal Officer
|
Tax withholdingCommon Stock | 1,352 | $231.67 | $313,217.84 |
DisclosureSEC source: 0001127602-25-010622 · form4.xml · nonDerivative · entry 2 van der Vaart Sandra D · CIK 0001537208 · EVP, Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,143.5397 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| March 27, 2025 Filed Mar 31, 2025 14:35 UTC |
van der Vaart Sandra DEVP, Chief Legal Officer
|
GrantCommon Stock | 3,325 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-010622 · form4.xml · nonDerivative · entry 1 van der Vaart Sandra D · CIK 0001537208 · EVP, Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,495.5397 F1 · kind: Shares acquired on March 27, 2025, pursuant to a performance award granted on February 11, 2022, relating to performance during the three-year period ended December 31, 2024. Read SEC document |
| March 27, 2025 Filed Mar 31, 2025 14:26 UTC |
EISENBERG GLENN AExecutive Vice President
|
Tax withholdingCommon Stock | 3,630 | $231.67 | $840,962.10 |
DisclosureSEC source: 0001127602-25-010618 · form4.xml · nonDerivative · entry 2 EISENBERG GLENN A · CIK 0001222831 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,920 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| March 27, 2025 Filed Mar 31, 2025 14:26 UTC |
EISENBERG GLENN AExecutive Vice President
|
GrantCommon Stock | 8,305 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-010618 · form4.xml · nonDerivative · entry 1 EISENBERG GLENN A · CIK 0001222831 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,550 F1 · kind: Shares acquired on March 27, 2025, pursuant to a performance award granted on February 11, 2022, relating to performance during the three-year period ended December 31, 2024. Read SEC document |
| March 27, 2025 Filed Mar 31, 2025 14:24 UTC |
BERBERIAN LANCEEVP, Special Advisor, Strategy
|
Tax withholdingCommon Stock | 1,353 | $231.67 | $313,449.51 |
DisclosureSEC source: 0001127602-25-010617 · form4.xml · nonDerivative · entry 2 BERBERIAN LANCE · CIK 0001102900 · EVP, Special Advisor, Strategy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,652 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| March 27, 2025 Filed Mar 31, 2025 14:24 UTC |
BERBERIAN LANCEEVP, Special Advisor, Strategy
|
GrantCommon Stock | 3,325 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-010617 · form4.xml · nonDerivative · entry 1 BERBERIAN LANCE · CIK 0001102900 · EVP, Special Advisor, Strategy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,005 F1 · kind: Shares acquired on March 27, 2025, pursuant to a performance award granted on February 11, 2022, relating to performance during the three-year period ended December 31, 2024. Read SEC document |
| March 27, 2025 Filed Mar 31, 2025 14:24 UTC |
Caveney Brian JEVP, Pres of ED, CMO & CSO
|
Tax withholdingCommon Stock | 2,109 | $231.67 | $488,592.03 |
DisclosureSEC source: 0001127602-25-010616 · form4.xml · nonDerivative · entry 2 Caveney Brian J · CIK 0001717915 · EVP, Pres of ED, CMO & CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,066.6573 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| March 27, 2025 Filed Mar 31, 2025 14:24 UTC |
Caveney Brian JEVP, Pres of ED, CMO & CSO
|
GrantCommon Stock | 4,840 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-010616 · form4.xml · nonDerivative · entry 1 Caveney Brian J · CIK 0001717915 · EVP, Pres of ED, CMO & CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,175.6573 F1 · kind: Shares acquired on March 27, 2025, pursuant to a performance award granted on February 11, 2022, relating to performance during the three-year period ended December 31, 2024. Read SEC document |
| March 27, 2025 Filed Mar 31, 2025 14:23 UTC |
Wilkinson Peter JSVP, Chief Accounting Officer
|
Tax withholdingCommon Stock | 359 | $231.67 | $83,169.53 |
DisclosureSEC source: 0001127602-25-010615 · form4.xml · nonDerivative · entry 2 Wilkinson Peter J · CIK 0001398138 · SVP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,883.2194 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| March 27, 2025 Filed Mar 31, 2025 14:23 UTC |
Wilkinson Peter JSVP, Chief Accounting Officer
|
GrantCommon Stock | 1,249 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-010615 · form4.xml · nonDerivative · entry 1 Wilkinson Peter J · CIK 0001398138 · SVP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,242.2194 F1 · kind: Shares acquired on March 27, 2025, pursuant to a performance award granted on February 11, 2022, relating to performance during the three-year period ended December 31, 2024. Read SEC document |
| March 27, 2025 Filed Mar 31, 2025 14:21 UTC |
Oyegunwa AkinboladeEVP, CIO & CTO
|
Tax withholdingCommon Stock | 198 | $231.67 | $45,870.66 |
DisclosureSEC source: 0001127602-25-010614 · form4.xml · nonDerivative · entry 2 Oyegunwa Akinbolade · CIK 0002042869 · EVP, CIO & CTO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,464.253 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| March 27, 2025 Filed Mar 31, 2025 14:21 UTC |
Oyegunwa AkinboladeEVP, CIO & CTO
|
GrantCommon Stock | 688 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-010614 · form4.xml · nonDerivative · entry 1 Oyegunwa Akinbolade · CIK 0002042869 · EVP, CIO & CTO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,662.253 F1 · kind: Shares acquired on March 27, 2025, pursuant to a performance award granted on February 11, 2022, relating to performance during the three-year period ended December 31, 2024. Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 13:16 UTC |
ANDERSON KERRII BDirector
|
SaleCommon Stock | 500 | $255.63 | $127,817.35 |
DisclosureSEC source: 0001127602-25-008647 · form4.xml · nonDerivative · entry 1 ANDERSON KERRII B · CIK 0001227159 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,166 Read SEC document |
| February 28, 2025 Filed Mar 4, 2025 13:41 UTC |
Schroeder Mark SEVP, Pres Diagnostics & COO
|
Exercise / conversionNon-qualified Stock Options · Derivative | 3,903 | $0.00 Strike: $131.43 | $0.00 |
DisclosureSEC source: 0001127602-25-007615 · form4.xml · derivative · entry 3 Schroeder Mark S · CIK 0001793112 · EVP, Pres Diagnostics & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,903 shares Expires 2029-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option (right to buy) granted pursuant to the Labcorp Holdings Inc. Amended and Restated 2016 Omnibus Incentive Plan. F3 · derivative.exercise_date: The options vested in three equal annual installments beginning on the date reflected in this column. Read SEC document |
| February 28, 2025 Filed Mar 4, 2025 13:41 UTC |
Schroeder Mark SEVP, Pres Diagnostics & COO
|
SaleCommon Stock | 5,339 | $249.23 | $1,330,638.97 |
DisclosureSEC source: 0001127602-25-007615 · form4.xml · nonDerivative · entry 2 Schroeder Mark S · CIK 0001793112 · EVP, Pres Diagnostics & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,960.1426 F1 · kind: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Read SEC document |
| February 28, 2025 Filed Mar 4, 2025 13:41 UTC |
Schroeder Mark SEVP, Pres Diagnostics & COO
|
Exercise / conversionCommon Stock | 3,903 | $131.43 | $512,971.29 |
DisclosureSEC source: 0001127602-25-007615 · form4.xml · nonDerivative · entry 1 Schroeder Mark S · CIK 0001793112 · EVP, Pres Diagnostics & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,299.1426 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Read SEC document |
| February 25, 2025 Filed Feb 27, 2025 15:07 UTC |
van der Vaart Sandra DEVP, Chief Legal Officer
|
SaleCommon Stock | 1,314 | $251.30 | $330,208.20 |
DisclosureSEC source: 0001127602-25-007067 · form4.xml · nonDerivative · entry 1 van der Vaart Sandra D · CIK 0001537208 · EVP, Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,170.5397 Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 14:03 UTC |
Summy Amy B.EVP, Chief Marketing Officer
|
SaleCommon Stock | 226 | $250.40 | $56,590.40 |
DisclosureSEC source: 0001127602-25-006779 · form4.xml · nonDerivative · entry 1 Summy Amy B. · CIK 0001805303 · EVP, Chief Marketing Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,544.5 F1 · kind: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 20:24 UTC |
Wilkinson Peter JSVP, Chief Accounting Officer
|
Exercise / conversionNon-qualified Stock Options · Derivative | 1,413 | $0.00 Strike: $163.63 | $0.00 |
DisclosureSEC source: 0001127602-25-005895 · form4.xml · derivative · entry 4 Wilkinson Peter J · CIK 0001398138 · SVP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,413 shares Expires 2030-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option (right to buy) granted pursuant to the Labcorp Holdings Inc. Amended and Restated 2016 Omnibus Incentive Plan. F3 · derivative.exercise_date: The option vested in three equal annual installments beginning on the date reflected in this column. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 20:24 UTC |
Wilkinson Peter JSVP, Chief Accounting Officer
|
SaleCommon Stock | 1,413 | $246.10 | $347,738.88 |
DisclosureSEC source: 0001127602-25-005895 · form4.xml · nonDerivative · entry 3 Wilkinson Peter J · CIK 0001398138 · SVP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,993.2194 Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 20:24 UTC |
Wilkinson Peter JSVP, Chief Accounting Officer
|
Exercise / conversionCommon Stock | 1,413 | $163.63 | $231,209.19 |
DisclosureSEC source: 0001127602-25-005895 · form4.xml · nonDerivative · entry 2 Wilkinson Peter J · CIK 0001398138 · SVP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,406.2194 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 11, 2025 Filed Feb 13, 2025 17:08 UTC |
Wilkinson Peter JSVP, Chief Accounting Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 123 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-004559 · form4.xml · derivative · entry 6 Wilkinson Peter J · CIK 0001398138 · SVP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,491 Underlying: Common Stock · 123 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. F7 · derivative.exercise_date: The Restricted Stock Units vested in three equal annual installments beginning on February 11, 2023 and are now fully vested. F7 · derivative.expiration_date: The Restricted Stock Units vested in three equal annual installments beginning on February 11, 2023 and are now fully vested. F6 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 11, 2025 Filed Feb 13, 2025 17:08 UTC |
Wilkinson Peter JSVP, Chief Accounting Officer
|
GrantRestricted Stock Unit · Derivative | 1,610 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-004559 · form4.xml · derivative · entry 5 Wilkinson Peter J · CIK 0001398138 · SVP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,614 Underlying: Common Stock · 1,610 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. F5 · derivative.exercise_date: The Restricted Stock Units vest in three equal annual installments beginning on February 11, 2026. F5 · derivative.expiration_date: The Restricted Stock Units vest in three equal annual installments beginning on February 11, 2026. F6 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 11, 2025 Filed Feb 13, 2025 17:08 UTC |
Wilkinson Peter JSVP, Chief Accounting Officer
|
GrantRestricted Stock Unit · Derivative | 480 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-004559 · form4.xml · derivative · entry 4 Wilkinson Peter J · CIK 0001398138 · SVP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,004 Underlying: Common Stock · 480 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. F5 · derivative.exercise_date: The Restricted Stock Units vest in three equal annual installments beginning on February 11, 2026. F5 · derivative.expiration_date: The Restricted Stock Units vest in three equal annual installments beginning on February 11, 2026. F6 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 11, 2025 Filed Feb 13, 2025 17:08 UTC |
Wilkinson Peter JSVP, Chief Accounting Officer
|
GrantNon-qualified Stock Options · Derivative | 1,500 | $0.00 Strike: $245.14 | $0.00 |
DisclosureSEC source: 0001127602-25-004559 · form4.xml · derivative · entry 3 Wilkinson Peter J · CIK 0001398138 · SVP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,500 Underlying: Common Stock · 1,500 shares Expires 2035-02-10 F3 · security: Employee stock option (right to buy) granted pursuant to the Labcorp Holdings Inc. Amended and Restated 2016 Omnibus Incentive Plan. F4 · derivative.exercise_date: The option vests in three equal annual installments beginning on the date reflected in this column. Read SEC document |
| February 11, 2025 Filed Feb 13, 2025 17:08 UTC |
Wilkinson Peter JSVP, Chief Accounting Officer
|
Tax withholdingCommon Stock | 41 | $245.14 | $10,050.74 |
DisclosureSEC source: 0001127602-25-004559 · form4.xml · nonDerivative · entry 2 Wilkinson Peter J · CIK 0001398138 · SVP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,344.2194 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| February 11, 2025 Filed Feb 13, 2025 17:08 UTC |
Wilkinson Peter JSVP, Chief Accounting Officer
|
Exercise / conversionCommon Stock | 123 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-004559 · form4.xml · nonDerivative · entry 1 Wilkinson Peter J · CIK 0001398138 · SVP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,385.2194 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. Read SEC document |
| February 11, 2025 Filed Feb 13, 2025 16:59 UTC |
Summy Amy B.EVP, Chief Marketing Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 201 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-004556 · form4.xml · derivative · entry 5 Summy Amy B. · CIK 0001805303 · EVP, Chief Marketing Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,359 Underlying: Common Stock · 201 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. F7 · derivative.exercise_date: The Restricted Stock Units vested in three equal annual installments beginning on February 11, 2023 and are now fully vested. F7 · derivative.expiration_date: The Restricted Stock Units vested in three equal annual installments beginning on February 11, 2023 and are now fully vested. F6 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 11, 2025 Filed Feb 13, 2025 16:59 UTC |
Summy Amy B.EVP, Chief Marketing Officer
|
GrantRestricted Stock Unit · Derivative | 690 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-004556 · form4.xml · derivative · entry 4 Summy Amy B. · CIK 0001805303 · EVP, Chief Marketing Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,560 Underlying: Common Stock · 690 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. F5 · derivative.exercise_date: The Restricted Stock Units vest in three equal annual installments beginning on February 11, 2026. F5 · derivative.expiration_date: The Restricted Stock Units vest in three equal annual installments beginning on February 11, 2026. F6 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.